Analyze Diet
Veterinary journal (London, England : 1997)2024; 305; 106129; doi: 10.1016/j.tvjl.2024.106129

Current insights into equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy.

Abstract: Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (eNAD/EDM) is an inherited neurodegenerative disease associated with vitamin E deficiency in the first year of life. It is the second most common cause of spinal ataxia in horses euthanized for neurologic disease. Equine NAD/EDM is characterized by neurologic signs including a symmetric proprioceptive ataxia (> grade 2/5) and a wide-base stance at rest. There are currently no antemortem tests for eNAD/EDM in any breed. Conclusive diagnosis requires postmortem histologic evaluation of the brainstem and spinal cord at necropsy. Research studies on antemortem biomarkers and genetic testing are ongoing. The development of a genetic test for eNAD/EDM would have widespread impact, even if it were breed specific. Currently, the best approach to eNAD/EDM is to focus on preventing cases by providing pregnant mares and foals with access to pasture. Alternatively, dams' diets can be supplemented with high doses of water-soluble RRR-α-tocopherol during the last trimester of gestation, with continued supplementation of foals through the first two years of life. It is important to measure horses' baseline serum vitamin E levels prior to supplementing. While considered generally safe, oversupplementation of vitamin E is possible and can lead to coagulopathies.
Publication Date: 2024-05-10 PubMed ID: 38734404DOI: 10.1016/j.tvjl.2024.106129Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (eNAD/EDM), an inherited neurodegenerative disease in horses linked to vitamin E deficiency during the first year of life. Current prevention methods and ongoing research into disease testing and diagnosis are also discussed.

Disease overview

  • Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (eNAD/EDM) is a neurodegenerative disease that horses inherit and are most likely to develop during their first year of life if they suffer from a vitamin E deficiency. This condition is the second most common reason for horses who showed spinal ataxia to be euthanized due to neurological disease.

Characteristics and Diagnosis

  • The eNAD/EDM disease possesses a few identifiable characteristics that primarily include sudden neurologic signs. Horses with eNAD/EDM would often exhibit symmetric ataxia, have a wide-based stance even when at rest, and exhibit proprioceptive defects. Despite these characteristics, there are no known antemortem tests for this disease yet in any horse breed.
  • As of now, a confirmed diagnosis for eNAD/EDM can only be obtained after a horse’s death, through a histologic evaluation of the horse’s brainstem and spinal cord at necropsy.

Research and Potential Testing

  • Research is actively ongoing in this field to find antemortem biomarker and genetic testing techniques. There is a wide interest in the development of a genetic test for eNAD/EDM, even if such a test were only effective for specific breeds. The availability of such a test could significantly impact the global equine community.

Prevention

  • Since no antemortem tests or treatments for eNAD/EDM currently exist, the best approach to counteract this disease is by preventive measures. Pregnant mares and foals should be allowed access to pasture or provided with a diet that includes high doses of the water-soluble vitamin RRR-α-tocopherol, especially during the dam’s last trimester and through the foal’s first two years of life.
  • However, it is crucial to measure a horse’s baseline serum vitamin E levels before providing supplementation because oversupplementation of vitamin E, whilst largely safe, can potentially lead to coagulopathies.

Cite This Article

APA
Young AE, Finno CJ. (2024). Current insights into equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy. Vet J, 305, 106129. https://doi.org/10.1016/j.tvjl.2024.106129

Publication

ISSN: 1532-2971
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 305
Pages: 106129

Researcher Affiliations

Young, Amy E
  • Center for Equine Health, School of Veterinary Medicine, University of California, Davis, CA, USA.
Finno, Carrie J
  • Center for Equine Health, School of Veterinary Medicine, University of California, Davis, CA, USA; Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA. Electronic address: cjfinno@ucdavis.edu.

MeSH Terms

  • Horses
  • Animals
  • Horse Diseases
  • Neuroaxonal Dystrophies / veterinary
  • Vitamin E Deficiency / veterinary
  • Vitamin E Deficiency / complications
  • Vitamin E / administration & dosage
  • Vitamin E / therapeutic use
  • Female
  • Pregnancy
  • Dietary Supplements / analysis

Conflict of Interest Statement

Declaration of Competing Interest None of the authors of this paper has a financial or personal relationship with other people or organisations that could inappropriately influence or bias the content of the paper.